In vivo toxicity of intravenously administered silica and silicon nanoparticles

Materials

Volumn 5, Issue 10, 2012, Pages 1873-1889

  Ivanov, Sergey ^a,b   Zhuravsky, Sergey ^a,b   Yukina, Galina ^b   Tomson, Vladimir ^b   Korolev, Dmitry ^a,b   Galagudza, Michael ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

In vivo toxicity; Silica nanoparticles; Silicon nanoparticles

Indexed keywords

ACUTE TOXICITY; BIOCHEMICAL MARKERS; BIOCHEMICAL PARAMETERS; HEMODYNAMIC PARAMETERS; HISTOLOGICAL STRUCTURE; IN-VIVO; INNER EAR; INTRA-GROUP; MEAN DIAMETER; OBSERVATION PERIOD; SILICA NANOPARTICLES; SILICON NANOPARTICLES; SPRAGUE-DAWLEY RATS; TARGETED DRUG DELIVERY;

AUDITION; BIOCHEMISTRY; DRUG DELIVERY; NANOPARTICLES; SILICA; SILICON; TOXICITY;

SILICON OXIDES;

EID: 84870153036     PISSN: None     EISSN: 19961944     Source Type: Journal    
DOI: 10.3390/ma5101873     Document Type: Article

References (31)

1. Ye, X.; Yang, D. Recent advances in biological strategies for targeted drug delivery. Cardiovasc. Hematol. Disord. Drug Targets 2009, 9, 206-221.
2. Lammers, T.; Hennink, W.E.; Storm, G. Tumour-targeted nanomedicines: Principles and practice. Br. J. Cancer 2008, 99, 392-397.
3. Galagudza, M.; Korolev, D.; Postnov, V.; Naumisheva, E.; Grigorova, Yu.; Uskov, I.; Shlyakhto, E. Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int. J. Nanomedicine 2012, 7, 1-8.
4. Ulbrich, W.; Lamprecht, A. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J. R. Soc. Interface 2010, 7, S55-S66.
5. Van den Hoven, J.M; van Tomme, S.R.; Metselaar, J.M.; Nuijen, B.; Beijnen, J.H.; Storm, G. Liposomal drug formulations in the treatment of rheumatoid arthritis. Mol. Pharm. 2011, 8, 1002-1015.
6. Galagudza, M.; Korolev, D.; Sonin, D.; Postnov, V.; Papayan, G.; Uskov, I.; Belozertseva, A.; Shlyakhto, E. Targeted drug delivery to ischemic heart with use of nanoparticulate carriers: Concepts, pitfalls and perspectives. J. Manuf. Technol. Manage. 2010, 21, 930-949.
7. Parveen, S.; Misra, R.; Sahoo, S.K. Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012, 8, 147-166.
8. Park, J.H.; Gu, L.; von Maltzahn, G.; Ruoslahti, E.; Bhatia, S.N.; Sailor, M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 2009, 8, 331-336.
9. Tang, F.; Li, L.; Chen, D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 2012, 24, 1504-1534.
10. Napierska, D.; Thomassen, L.C.; Lison, D.; Martens, J.A.; Hoet, P.H. The nanosilica hazard: Another variable entity. Part. Fibre Toxicol. 2010, 7, 39.
11. Slowing, I.I.; Vivero-Escoto, J.L.; Wu, C.W.; Lin, V.S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60, 1278-1288.
12. 2 nanoparticles biocompatibility and their potential for gene delivery and silencing. Nanoscale 2012, 4, 486-495.
13. Ye, Y.Y.; Liu, J.W.; Chen, M.C.; Sun, L.J.; Lan, M.B. In vitro toxicity of silica nanoparticles in myocardial cells. Environ. Toxicol. Pharmacol. 2010, 29, 131-137.
14. Napierska, D.; Thomassen, L.C.; Rabolli, V.; Lison, D.; Gonzalez, L.; Kirsch-Volders, M.; Martens, J.A.; Hoet, P.H. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5, 846-853.
15. Kumar, R.; Roy, I.; Ohulchanskky, T.Y.; Vathy, L.A.; Bergey, E.J.; Sajjad, M.; Prasad, P.N. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4, 699-708.
16. Xie, G.; Sun, J.; Zhong, G.; Shi, L.; Zhang, D. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch. Toxicol. 2010, 84, 183-190.
17. Nishimori, H.; Kondoh, M.; Isoda, K.; Tsunoda, S.; Tsutsumi, Y.; Yagi, K. Silica nanoparticles as hepatotoxicants. Eur. J. Pharm. Biopharm. 2009, 72, 496-501.
18. Nishimori, H.; Kondoh, M.; Isoda, K.; Tsunoda, S.; Tsutsumi, Y.; Yagi, K. Histological analysis of 70-nm silica particles-induced chronic toxicity in mice. Eur. J. Pharm. Biopharm. 2009, 72, 626-629.
19. Cho, M.; Cho, W.S.; Choi, M.; Kim, S.J.; Han, B.S.; Kim, S.H.; Kim, H.O.; Sheen, Y.Y.; Jeong, J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 2009, 189, 177-183.
20. Isoda, K.; Hasezaki, T.; Kondoh, M.; Tsutsumi, Y.; Yagi, K. Effect of surface charge on nano-sized silica particle-induced liver injury. Pharmazie 2011, 66, 278-281.
21. Canham, L.T. Bioactive silicon structure fabrication through nanoetching techniques. Adv. Mater. 1995, 7, 1033-1037.
22. Aggarwal, P.; Hall, J.B.; McLeland, C.B.; Dobrovolskaia, M.A.; McNeil, S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 61, 428-437.
23. Graf, C.; Gao, Q.; Schütz, I.; Noufele, C.N.; Ruan, W.; Posselt, U. Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells. Langmuir 2012, 28, 7598-7613.
24. Abrashkin, K.A.; Izumikawa, M.; Miyazawa, T.; Wang, C.H.; Crumling, M.A.; Swiderski, D.L.; Beyer, L.A.; Gong, T.W.; Raphael, Y. The fate of outer hair cells after acoustic or ototoxic insults. Hear. Res. 2006, 218, 20-29.
25. Xie, G.; Sun, J.; Zhong, G. Tissular localization and excretion of intravenously administered silica nanoparticles of different sizes. J. Nanopart. Res. 2012, 14, 671.
26. Liu, T.; Li, L.; Teng, X.; Huang, X.; Liu, H.; Chen, D.; Ren, J.; He, J.; Tang, F. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 2011, 32, 1657-1668.
27. Hao, Y.; Yang, X.; Song, S.; Huang, M.; He, C.; Cui, M.; Chen, J. Exploring the cell uptake mechanism of phospholipid and polyethylene glycol coated gold nanoparticles. Nanotechnology 2012, 23, doi:10.1088/0957-4484/23/4/045103.
28. Gupta, A.; Wiggers, H. Surface chemistry and photoluminescence property of functionalized silicon nanoparticles. Phys. E 2009, 41, 1010-1014.
29. Goller, B.; Polisski, S.; Wiggers, H.; Kovalev, D. Silicon nanocrystals dispersed in water: photosensitizers for molecular oxygen. Appl. Phys. Lett. 2010, 96, doi:10.1063/1.3432349.
30. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals; The National Academies Press: Washington, DC, USA, 2011.
31. Tanaka, K.; Morimoto, J.; Kon, S.; Kimura, C.; Inobe, M.; Diao, H.; Hirschfeld, G.; Weiss, J.M.; Uede, T. Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver. Am. J. Pathol. 2004, 164, 567-575.